期刊文献+

干扰素-γ对小鼠白血病细胞株FBL-3体外侵袭能力影响 被引量:3

Effect of interferon-γ on the invasive capacity of leukemia cell line FBL-3
原文传递
导出
摘要 目的:探讨干扰素-γ不同剂量、不同作用时间对小鼠白血病细胞FBL-3体外侵袭能力的影响。方法:小鼠白血病细胞株FBL-3分为6组,其中A组为空白对照组;B^E组分别用干扰素-γ5,50,200,500 ng/mL处理48 h;F组为干扰素-γ50 ng/mL处理2周。应用Transwell侵袭模型检测各组FBL-3细胞的体外侵袭力,采用单因素方差分析进行比较。结果:与A组比较,C、D和E组穿过Matrigel胶的FBL-3细胞数目明显减少,且存在剂量依赖性效应(P<0.05)。F组细胞侵袭能力增强,明显高于对照组(P<0.05)。结论:干扰素-γ短期作用(48 h)可以剂量依赖性方式明显抑制FBL-3细胞的体外侵袭能力;小剂量干扰素-γ长期作用可促进FBL-3细胞的侵袭能力。 Objective To investigate the effect of interferon-γ on the invasive capacity of leukemia cell line FBL-3 in mice.Methods FBL-3 cells were divided into 6 group in mice with leukemia.Group B(interferon-γ 5 ng/mL),group C(interferon-γ 50 ng/mL),group D(interferon-γ 200 ng/mL),and group E(interferon-γ 500 ng/mL) were treated for 48 hours.Group F(interferon-γ 50 ng/mL) was treated for consecutive 2 weeks.Group A was blank control group.The invasive capacity of FBL-3 in each group were assayed with Transwell membrane invasion culture system,and one-way ANOVA analysis was used to analyze the results.Results Compared with group A,the numbers FBL-3 cells passing through Matrigel in group C,D and E were significantly fewer and dose-dependent(P〈0.05).On the contrary,the invasive capacity of FBL-3 cell was remarkably enhanced in group F compared with group A.Conclusion Interferon-γ can inhibit the invasive capacity of the FBL-3 cell in a short period(48 hours) in dose-dependent manner,but the consecutive effects(2 weeks) of low dose interferon-γ(50 ng/mL) can significantly promote FBL-3 cell invasiveness.
出处 《中华实用诊断与治疗杂志》 2011年第6期528-529,共2页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金(30500590)
关键词 白血病 干扰素-Γ 侵袭 Leukemia interferon-γ invasion
  • 相关文献

参考文献7

二级参考文献50

  • 1李玉峰,王春玲,丁帮和,朱家斌,郑绍同,于亮,钱墨生.高三尖杉酯碱治疗慢性粒细胞白血病的远期疗效观察[J].中华血液学杂志,2004,25(6):378-379. 被引量:17
  • 2王锁荣,孙志坚,马志俊,张东军,蒋安平,任金华.促炎与抗炎细胞因子在肾综合征出血热发病中的作用[J].中华传染病杂志,2007,25(1):43-46. 被引量:21
  • 3Terajima M, Hayasaka D, Maeda K, et al. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers[J]. Immunol I.ett, 2007,113(2):117-120.
  • 4Markotic A, Hensley L, Daddario K, et al. Pathogenic hantaviruses elicit different immunoreaetions in THP 1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells[J]. Coil Antropol, 2007,31 (4) : 1159-1167.
  • 5Hayasaka D, Maeda K, Ennis F A, et al. Increased permeability of human endothelial cell line EA. hy926 induced by hantavirus specific cytotoxic T lymphocytes [J]. Virus Res, 2007,123(2):120-127.
  • 6Giuntl S, Pinach S, Arnaldi L, et al. The MCP 1/CCR2 system has direct proinflammatory effects in human mesangial cells[J].Kidney Int,2006,69(5) :856-863.
  • 7Maus U, Henning S, Wenschuh H, et al. Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow[J]. Am J Physiol Heart Circ Physiol, 2002,283(6) : H2584-H2591.
  • 8MaslinC L, Kedzierska K, Webster N L, et al. Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection[J]. Curr HIV Res,2005,3 (4) :303-317.
  • 9Ogura H, Tanaka H, Koh T, et al. Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome [J]. J Trauma,2004,56(4):823-830.
  • 10Reinhart K, Bayer O, Brunkhorst F, et al. Markers of endothelial damage in organ dysfunction and sepsis[J].Crit Care Med,2002,30(5 Suppl) :S302-312.

共引文献16

同被引文献61

  • 1闵红波,黄勤,郭志勇,王建文,步世忠.雷公藤红素诱导视网膜母细胞瘤Y79细胞凋亡及对凋亡核因子-κB的影响[J].中国中医眼科杂志,2004,14(3):146-148. 被引量:13
  • 2陈慎宝,丁如宁.槐耳菌质成分对小鼠免疫功能的影响[J].食用菌学报,1995,2(1):21-25. 被引量:37
  • 3周鋆,吴叔明,陈晓宇,彭延申.雷公藤红素对三硝基苯磺酸诱导的大鼠结肠炎的保护作用[J].胃肠病学,2007,12(3):144-147. 被引量:13
  • 4Corson T W, Crews C M. Molecular understanding and modern application of traditional medicines: triumphs and trials[J]. Cell, 2007,130 (5) : 769-774.
  • 5Sethi G, Ahn K S, Pandey M K, et al. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gcne products and TAKl-mediated NF-kappaB activatio[J]. Blood, 2007,109(7):2727-2735.
  • 6Kondo K, Yao M, Yoshida M, etal. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters[J]. Genes Chromosomes Cancer,2002,34(l) :58-68.
  • 7Sudrez C, Morales R, Munoz E, et al. Molecular basis for the treatment of renal cell carcinoma[J]. Clin Transl Oncol,2010,12 (1):15-21.
  • 8Ljungberg B J, Jacobsen J, Rudolfsson S H, et al. Different vascular endothelial growth factor (VEGF), VEGF receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma[J]. BJU Int,2006,98(3):661-667.
  • 9Dobrzanski M J, Reome J B, Hollenbaugh J A, etal. Tcl and Tc2 effector cell therapy elicit long term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses[J]. J Immunol,2004, 172(3) :1380 -1390.
  • 10Nonomura N, Miki T, Yokoyama M, et al. Fas/APO-I- mediated apoptosis of human renal cell carcinoma[J]. Biochem Biophys Res Commun,1996,229(3) :945-951.

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部